New Amsterdam Sciences, based in Scottsdale, AZ, is a biopharmaceutical company dedicated to developing innovative therapies for persistent inflammatory conditions driven by oxidative stress and ROS inflammation. With a focus on Rheumatoid Arthritis, Infectious Disease, and CNS disorders, the company aims to bring novel, safe, and effective treatments to patients.
From addressing COVID-19 to developing therapies for Influenza, Progressive Supranuclear Palsy, and radiation mitigators, New Amsterdam Sciences leverages its anti-inflammatory platform to advance treatments that enhance the lives of patients across various medical fields. Committed to staying ahead of the rapidly evolving pandemic, the company's research and development efforts aim to make a meaningful impact in the healthcare industry.
Generated from the website